Latest news and press releases about Autonomix Medical, Inc. (AMIX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Price
| Price | $4.12 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.70 |
| EV / EBITDA | 0.06 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -267.73% |
| Return on Invested Capital | -518.15% |
| Return on Assets | -404.67% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: AIM · BBLG · DHAI · FLGC · HSCS · KALA · MOVE
Explore sector: Healthcare · Medical - Devices
More sections of AMIX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks